Catalyst Wire Dossier Catalyst Wire Dossier

cabotegravir

cabotegravir · ViiV Healthcare
Drug timelines are a Plus or Pro feature.

39 regulatory and trial events tracked for cabotegravir, covering 2010-08-31 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age [Phase 1, Phase 2]

See pricing